Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

207 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Completed

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

NCT04420598

Conditions
Advanced Breast Cancer, Brain Diseases, Brain Metastases, +19 more
Locations
  • Champalimaud Center for the Unknown Lisbon, Portugal
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE (IPO Porto) Porto, Portugal
  • Institut Català d'Oncologica ICO Badalona Badalona, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
View all 16 locations
View Trial Details
Completed

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

NCT04246671

Conditions
Chordoma, HER2-positive Breast Cancer, Neoplasms, +2 more
Locations
  • Mayo Clinic - Phoenix Scottsdale, Arizona, United States
  • Providence Saint John's Health Center Santa Monica, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

NCT03530696

Conditions
Breast Cancer, Breast Cancer Stage, Breast Diseases, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedar-Sinai Beverly Hills, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 16 locations
View Trial Details
Completed

PRS-343 in HER2-Positive Solid Tumors

NCT03330561

Conditions
HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Los Angeles (UCLA) Santa Monica, California, United States
  • Georgetown University, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View Trial Details
Completed

PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors

NCT03650348

Conditions
HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCLA Health Santa Monica, California, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View Trial Details

Related conditions